Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 30 of 95, showing 5 Applications out of 471 total, starting on record 146, ending on 150

# Protocol No Study Title Investigator(s) & Site(s)

146.

ECCT/21/12/04   FAST Study
    Assessments of the EFficacy, the onset-of-Action and the Safety of Tot'héma® in adults with moderate iron deficiency anaemia   
Principal Investigator(s)
1. Dr. Francis Xavier Otieno Odawa
Site(s) in Kenya
1. MOI University Teaching and Referral Hospital (Nandi county)
2. UNIM Research and Training Centre (Kisumu county)
3. Kenyatta National Hospital (Nairobi City county)
 
View

147.

ECCT/21/12/02   The WHO ACTION Trial
    ACTION III: A multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes   
Principal Investigator(s)
1. Frederick Namenya Were
2. John Kinuthia
3. Zahida Parveen Qureshi
Site(s) in Kenya
1. Coast General Teaching and Referral Hospital (Mombasa county)
2. Thika Level 5 Hospital (Kiambu county)
3. Nakuru Level 5 Hospital (Nakuru county)
 
View

148.

ECCT/21/11/08   GBT_131 Inclacumab-Ps 3 Trial.
    A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vaso-occlusive Crises   
Principal Investigator(s)
1. Videlis N Nduba
2. Prof. Jessie N Githanga
3. Fredrick Sirwa Chite
4. Bernhards Ragama Ogutu
Site(s) in Kenya
1. KEMRI/CRDR (Nairobi City county)
2. KEMRI Siaya Clinical Research Annex (Siaya county)
3. Gertrude’s Children’s Hospital. (Nairobi City county)
4. Strathmore University Medical Centre (Nairobi City county)
5. International Cancer Institute (ICI)-Eldorate (Uasin Gishu county)
 
View

149.

ECCT/21/11/07   lidERA
    A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF ADJUVANT GIREDESTRANT COMPARED WITH PHYSICIAN'S CHOICE OF ADJUVANT ENDOCRINE MONOTHERAPY IN PATIENTS WITH ESTROGEN RECEPTORPOSITIVE, HER2-NEGATIVE EARLY BREAST CANCER   
Principal Investigator(s)
1. Fredrick Asirwa Chite
Site(s) in Kenya
1. International Cancer Institute (ICI) (Uasin Gishu county)
2. Aga Khan University Hospital (Nairobi City county)
 
View

150.

ECCT/21/11/06   RESOLVE
    A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease    
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. KEMRI/CRDR Siaya Clinical Research Annex (Siaya county)
2. KEMRI CRDR Clinical Research Clinic Nairobi (Nairobi City county)
 
View